CD8A and hepatocellular carcinoma: Previous studies have shown that the density of CD8+ T cells infiltrating tumors is associated with longer survival in HCC patients (15), and the reduction in the depletion and dysfunction of CD8+ T cells is one of the current strategies for the treatment of tumors.